Advertisement

The Role of Radical Prostatectomy in the Treatment of Cancer of the Prostate

  • Herbert Lepor
Part of the Cancer Treatment and Research book series (CTAR, volume 46)

Abstract

Radical perineal prostatectomy was originally described by Kuchler in Germany in 1866 [1]. Hugh Hampton Young modified the perineal approach to radical prostatectomy by making the operation more anatomical and practical [2]. Young’s original technique was associated with urinary-incontinence in approximately 50% of cases [3]. The surgical approach to radical prostatectomy has undergone many additional modifications and refinements. Vest described a technique for approximating the bladder to the urethra so that tension would be taken off the external sphincter [4]. The anastamosis was performed using mattress sutures placed anteriorly and laterally. Jewett further modified the anastamosis by substituting simple sutures for Vest’s mattress sutures and by providing a mattress suture that approximated the anterolateral bladder wall to the urethra [4]. The water tight anastomosis of the bladder and urethra decreased the incidence of incontinence and anastomotic strictures.

Keywords

Prostate Cancer Radical Prostatectomy Bladder Outlet Obstruction Radical Retropubic Prostatectomy Johns Hopkins Hospital 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kuchler H: Über prostataver-grosserungen. Deutsch Klin 18: 458, 1986.Google Scholar
  2. 2.
    Young HH: The early diagnosis and radical cure of carcinoma of the prostate — Being a study of 40 cases and presentation of a radical operation which was carried out in four cases. Johns Hopkins Hops Bull 16: 315–321, 1905.Google Scholar
  3. 3.
    Jewett HJ: The results of radical perineal prostatectomy. JAMA 210: 324–325, 1969.PubMedCrossRefGoogle Scholar
  4. 4.
    Hodges CV: Vesicourethral anastamosis after radical prostatectomy: Experience with the Jewett modification. J Urol 118: 209–210, 1977.PubMedGoogle Scholar
  5. 5.
    Miliin T: Retropubic Urinary Surgery. Williams and Wilkins, Baltimore, 1947.Google Scholar
  6. 6.
    Middeleton AW Jr: Pelvic lymphadenectomy with modified radical retropubic prostatectomy as a single operation: Technique used and results in 50 consecutive cases. J Urol 125: 353–356, 1981.Google Scholar
  7. 7.
    Kopecky AA, Laskowski TZ, Scott R, Jr: Radical retropubic prostatectomy in the treatment of prostatic carcinoma. J Urol 103: 641–644, 1970.PubMedGoogle Scholar
  8. 8.
    Middleton AW Jr: A comparison of the morbidity associated with radical prostatectomy with and without pubectomy. J Urol 117: 202–205, 1977.PubMedGoogle Scholar
  9. 9.
    Lieskovsky G, Skinner DG: Technique of radical retropubic prostatectomy with limited pelvic node dissection. Urol Clin North Am 10: 187–198, 1983.PubMedGoogle Scholar
  10. 10.
    Crawford ED, Kiker JD: Radical retropubic prostatectomy. J Urol 129: 1145–1148, 1983.PubMedGoogle Scholar
  11. 11.
    Igel TC, Barrett DM, Segura JW, Benson RC Jr, Rife CC: Preoperative and postoperative complications from bilateral pelvic lymphadenectomy and radical retropubic prostatectomy. J Urol 137: 1186–1191, 1987.Google Scholar
  12. 12.
    Lepor H, Walsh PC: The role of radical prostatectomy in the management of Stage B adenocarcinoma of the prostate. In: Prostate Cancer, Part B: Imaging Techniques, Radiotherapy, Chemotherapy, and Management Issues, Murphy GP, Khoury S, Ross R, Châtelain C, Denis L (eds). Alan R. Liss, New York, 1987, pp. 343–356.Google Scholar
  13. 13.
    Walsh PC, Donker PJ Impotence following radical prostatectomy: Insight into etiology and prevention. J Urol 128: 492–497, 1982.PubMedGoogle Scholar
  14. 14.
    Walsh PC, Lepor H, Eggleston JC: Radical prostatectomy with preservation of sexual function: Anatomical and pathological considerations. Prostate 4: 473–485, 1983.PubMedCrossRefGoogle Scholar
  15. 15.
    Lepor H, Gregerman M, Crosby R, Mostofi FK, Walsh PC: 1985. Precise localization of the autonomic nerves from the pelvic plexus to the corpora cavernosa. A detailed anatomical study of the adult male pelvis. J Urol 133: 207–212, 1985.Google Scholar
  16. 16.
    Eggelston JC, Walsh PC: Radical prostatectomy with preservation of sexual function: Pathologic findings in the first 100 cases. J Urol 134: 1146–1148, 1985.Google Scholar
  17. 17.
    Young HH, Franz WA: Some new methods in the treatment of carcinoma of the lower genitourinary tract with radium. J Urol 1: 505–541, 1917.Google Scholar
  18. 18.
    Hultberg S: Results of treatment with radiotherapy in carcinoma of the prostate. Acta Radiol 27: 339–350, 1946.PubMedCrossRefGoogle Scholar
  19. 19.
    Taylor WJ: Radiation oncology: Cancer of the prostate. Cancer 39: 856–861, 1977.PubMedCrossRefGoogle Scholar
  20. 20.
    Mollenkamp JS, Cooper JF, Kagan AR: Clinical experience with supervoltage radiotherapy in carcinoma of the prostate: A preliminary report. J Urol 113: 374–377, 1975.PubMedGoogle Scholar
  21. 21.
    Ray GR, Cassady JR, Bagshaw MA: Definitive radiation therapy of carcinoma of the prostate. Ther Radiol 106: 407–417, 1973.Google Scholar
  22. 22.
    Bagshaw MA, Ray RG, Pistenna DA, et al.: External beam radiation therapy of primary carcinoma of the prostate. Cancer 36: 723–728, 1975.PubMedCrossRefGoogle Scholar
  23. 23.
    Rhamy RK, Wilson SK, Caldwell WL: Biopsy-proved tumor following definitive irradiation for resectable carcinoma of the prostate. J Urol 197: 627–630, 1972.Google Scholar
  24. 24.
    Goldstein I, Feldman MI, Deckers PJ, Babayan RK, Krane RJ: Radiation-associated impotence. JAMA 251: 903–910, 1984.PubMedCrossRefGoogle Scholar
  25. 25.
    Isaacs JT: Antagonistic effect of androgen on prostatic cell death. Prostate 5:545–547,1984.PubMedCrossRefGoogle Scholar
  26. 26.
    Benson MC: Management of primary Stage D prostatic cancer. In: Prostate Cancer, Part B: Imaging Techniques, Radiotherapy, Chemotherapy, and Management Issues. Murphy GP, Khoury S, Kuss R, Châtelain C, Denis L (eds). Alan R. Liss, New York, 1987, pp. 411–428.Google Scholar
  27. 27.
    National Institutes of Health Consensus Development Conference June 15–17, 1987. The management of clinically localized prostate cancer. J Urol 138: 1369–1375, 1987.Google Scholar
  28. 28.
    Scardino PT, Wheeler TM: Prostatic biopsy after irradiation therapy for prostatic cancer. Urology 25 (Suppl.): 39–46, 1985.PubMedGoogle Scholar
  29. 29.
    Freiha FS, Bagshaw MA: Carcinoma of the prostate: Results of post-irradiation biopsy. Prostate 5: 19–25, 1984.PubMedCrossRefGoogle Scholar
  30. 30.
    Schellhammer PF, Ladaga LE, El-Mahdi A: Histological characteristics of prostatic biopsies after 125iodine implantation. J Urol 123: 700–705, 1980.PubMedGoogle Scholar
  31. 31.
    Fleischmann J, Catalona WJ: Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol 134: 498–500, 1985.PubMedGoogle Scholar
  32. 32.
    Bauer WC, McGavran MH, Carlin MR: Unsuspected carcinoma of the prostate in suprapubic prostatectomy specimens: A clinicopathological study of 55 consecutive cases. Cancer 13: 370–378, 1960.PubMedCrossRefGoogle Scholar
  33. 33.
    Greene LF, Simon HB: Occult carcinoma of the prostate: Clinical and therapeutic study of eighty-three cases. JAMA 158: 1494–1498, 1955.Google Scholar
  34. 34.
    Sheldon CA, Williams RD, Fraley EE: Incidental carcinoma of the prostate: A review of the literature and critical reappraisal of classification. J Urol 124: 626–631, 1980.PubMedGoogle Scholar
  35. 35.
    Jewett JC: The present status of radical prostatectomy for Stages A and B prostatic cancer. Urol Clin North Am 2: 105–124, 1975.PubMedGoogle Scholar
  36. 36.
    Cantrell BB, DeKlerk DP, Eggleston JC, Boitnott JK, Walsh PC: Pathological factors that influence prognosis is Stage A prostatic cancer: The influence of extent versus grade. J Urol 125: 516–520, 1981.PubMedGoogle Scholar
  37. 37.
    Epstein JI, Eggleston JC, Pauli G, Walsh PC: Prognosis of untreated Stage Ax prostate carcinoma: A study of 94 cases with extended follow-up. J Urol 136: 837–839, 1986.PubMedGoogle Scholar
  38. 38.
    Blute ML, Zincke H, Farrow GM: Long-term followup of young patients with Stage A adenocarcinoma of the prostate. J Urol 136: 840–843, 1986.PubMedGoogle Scholar
  39. 39.
    Byar DP, Mostofi FK: Carcinoma of the prostate: Prognostic evaluation of certain pathologic features in 208 radical prostatectomies. Cancer 30: 5–13, 1972.PubMedCrossRefGoogle Scholar
  40. 40.
    McNeal JE: Origin and development of carcinoma in the prostate. Cancer 23: 24–34, 1969.Google Scholar
  41. 41.
    McNeal JE, Price HM, Redwine EA, Freiha FS, Stamey TS: Stage A versus Stage B adenocarcinoma of the prostate: Morphological comparison and biological significance. J Urol 139: 61–65, 1988.PubMedGoogle Scholar
  42. 42.
    McMillen SM, Wettlauter JN: The role of repeat transurethral biopsy in Stage A carcinoma of the prostate. J Urol 116: 759–760, 1976.PubMedGoogle Scholar
  43. 43.
    Carroll PR, Leitner TC, Yen TSB, Watson RA, Williams RD: Incidental carcinoma of the prostate: Significance of staging transurethral resection. J Urol 133: 811–814, 1985.PubMedGoogle Scholar
  44. 44.
    Epstein JI, Oesterling JE, Walsh PC: The volume and anatomic location of residual tumor in radical prostatectomy specimens removed for Stage A1 prostate cancer. J Urol 139: 975–979, 1988.PubMedGoogle Scholar
  45. 45.
    Carlton CE J, Scardino PT: Combined interstitial and external irradiation for prostatic cancer. In: Prostate Cancer, Part B: Imaging Techniques, Radiotherapy, Chemotherapy, and Management Issues, Murphy GP, Khoury S, Kuss R, Chatelain C, Denis N (eds). Alan R. Liss, New York, 1987, pp. 141–169.Google Scholar
  46. 46.
    Walsh PC, Jewett HJ: Radical surgery for prostatic cancer. Cancer 45: 1906–1911, 1980.PubMedGoogle Scholar
  47. 47.
    Walsh PC, Lepor H: The role of radical prostatectomy in the management of prostatic cancer. Cancer 60: (Suppl.) 526–537, 1987.PubMedCrossRefGoogle Scholar
  48. 48.
    Leibel SA, Hanks GE, Kramer S: Patterns of care outcome studies: Results of the national practice in adenocarcinoma of the prostate. Int J Radiat Oncol Biol Phys 10: 401–408, 1984.PubMedCrossRefGoogle Scholar
  49. 49.
    Schellhammer PF, El-Mahdi AM: Pelvic complications after definitive treatment of prostate cancer by interstitial or external beam radiation. Urology 21: 451–457, 1983.PubMedCrossRefGoogle Scholar
  50. 50.
    Berlin BB, Cornwell PM, Connelly RR, Eisenberg H: Radical perineal prostatectomy for carcinoma of the prostate: Survival in 143 cases treated from 1935 to 1958. J Urol 99: 97–101, 197-.Google Scholar
  51. 51.
    Dees JE: Radical perineal prostatectomy for carcinoma. J Urol 104: 160–162, 1970.PubMedGoogle Scholar
  52. 52.
    Belt E, Schroeder FH: Total perineal prostatectomy for carcinoma of the prostate. J Urol 107: 91–96, 1972.PubMedGoogle Scholar
  53. 53.
    Davis WH, Scardino PL, Carlton FE: Radical prostatectomy: A 20-year overview. J Urol 108: 604–608, 1972.PubMedGoogle Scholar
  54. 54.
    Williams J, Marshall VF, Gray GF Jr: Radical perineal prostatectomy with bilateral orchiectomy for carcinoma of the prostate. J Urol 113: 380–384, 1975.Google Scholar
  55. 55.
    Veenema RJ, Gursel EO, Lattimer JK: Radical retropubic prostatectomy for cancer: A 20-year experience. J Urol 117: 330–331, 1977.PubMedGoogle Scholar
  56. 56.
    Elder JS, Gibbons RP, Correa RJ Jr, Brannen GE: Efficacy of radical prostatectomy for Stage A2 carcinoma of the prostate. Cancer 56: 2151–2154, 1985.PubMedCrossRefGoogle Scholar
  57. 57.
    Jewett HJ: The case for radical perineal prostatectomy. J Urol 103: 195–199, 1970.PubMedGoogle Scholar
  58. 58.
    Jewett HJ, Eggleston JC, Yawn DH Radical prostatectomy in the management of carcinoma of the prostate: Probable causes of some therapeutic failures. J Urol 107: 1034–1040, 1972.PubMedGoogle Scholar
  59. 59.
    Jewett HJ, Bridge RW, Gray GF Jr, Shelley WM: The palpable nodule of prostatic cancer. JAMA 203: 403–406, 1968.PubMedCrossRefGoogle Scholar
  60. 60.
    Jewett HJ: Treatment of early cancer of the prostate. JAMA 183: 373–375, 1963.Google Scholar
  61. 61.
    Elder JS, Jewett HJ, Walsh PC: Radical perineal prostatectomy for clinical stage B2 carcinoma of the prostate. J Urol 127: 704–706, 1982.PubMedGoogle Scholar
  62. 62.
    Jewett HJ: 1980. Radical perineal prostatectomy for palpable, clinically localized nonobstructive cancer: Experience at the Johns Hopkins Hospital 1909–1963, J Urol 124: 492–494, 1980.Google Scholar
  63. 63.
    Lepor H, Kimball AW, Walsh PC: Cause specific actuarial survival analysis: A useful method for reporting survival data in men with clinically localized carcinoma of the prostate. J Urol, in press, 1988.Google Scholar
  64. 64.
    Byar DP, Corle DK: Veterans Administration Cooperative Urological Research Group. VACURG randomized trial of radical prostatectomy for Stages I and II prostate cancer. Urology 17: (Suppl): 7–11, 1981.PubMedGoogle Scholar
  65. 65.
    Madsen PO, Maigaard S, Corle DK, Byar DP: Radical prostatectomy for carcinoma of the prostate, Stage I and II: New results of the Veterans Administration Cooperative Urological Research Group. In: Proceedings of International Symposium on the Treatment of Carcinoma on the Prostate, Berlin, December 1978, Rosa A, Fiedler U (eds). Urologische Klinik, Klinikum Steglitz, Freie Universität, Berlin, 1980, p. 46.Google Scholar
  66. 66.
    Walsh PC: Randomized study of prostate cancer. Urology 18: 219, 1981.PubMedCrossRefGoogle Scholar
  67. 67.
    Byar DP, Corle DK Randomized study of prostatic cancer. Urology 18: 219–220, 1981.CrossRefGoogle Scholar
  68. 68.
    Walsh PC: Radical retropubic prostatectomy. In: Campbell’s Urology, Vol V, Walsh PC, Gittes R, Perlmutter AD, Stamey TA (eds). WB Saunders, Philadelphia, 1986, pp. 2754–2775.Google Scholar
  69. 69.
    Skinner EC, Liewskovsky G, Skinner DG: Radical cystectomy in the elderly patient. J Urol 131: 1065–1968, 1984.PubMedGoogle Scholar
  70. 70.
    Wood DP, Montie JE, Maatman TJ, Beck GJ: Radical cystectomy for carcinoma of the bladder in the elderly patient. J Urol 138: 46–48, 1987.PubMedGoogle Scholar
  71. 71.
    Chapp RT, Whitmore WF: Delayed treatment of prostatic carcinoma. Am Urol Assoc Mtg, 1980, paper #234.Google Scholar
  72. 72.
    Middleton AW Jr: Radical prostatectomy for carcinoma in men more than 69 years old. J Urol 138: 1185–1188, 1987.PubMedGoogle Scholar
  73. 73.
    Oesterling JE, Brendler CB, Epstein JJ, Kimball AW Jr, Walsh PC: Correlation of clinical stage, serum prostatic acid phosphatase, and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate. J Urol 138: 92–98, 1987.PubMedGoogle Scholar
  74. 74.
    McLaughlin AP, Saltzstein SL, McCullough DL: Prostatic carcinoma: Incidence and location of unsuspected lymphatic metastasis. J Urol 115: 89–94, 1976.PubMedGoogle Scholar
  75. 75.
    Sidi AA, Lange PH: Is staging of the patient important? In: Problems in Urology, Paulson DF (ed). JB Lippincott, Philadelphia, 1987, pp. 12–20.Google Scholar
  76. 76.
    Schroeder FH, Belt E: Carcinoma of the prostate: A study of 213 patients with Stage C tumors treated by total perineal prostatectomy. J Urol 114: 257–260, 1975.PubMedGoogle Scholar
  77. 77.
    Blackard CE, Byar DP, Jordan WP Jr: Orchiectomy for advanced prostatic carcinoma: A réévaluation. Urol 1: 553–560, 1973.PubMedCrossRefGoogle Scholar
  78. 78.
    Tomlinson, RL, Currie DP, Boyce WH: Radical prostatectomy: Palliation for Stage C carcinoma of the prostate. J Urol 117: 85–87, 1977.PubMedGoogle Scholar
  79. 79.
    Boxer RJ, Kaufman JJ, Goodwin WE: Radical prostatectomy for carcinoma of the prostate, 1951–1976: A review of 329 patients. J Urol 117: 208–213, 1977.PubMedGoogle Scholar
  80. 80.
    Zincke H, Utz DC, Benson RC Jr, Patterson DE: Bilateral pelvic lymphadenectomy and radical retropubic prostatectomy for Stage C adenocarcinoma of prostate. Urol 24: 532–539, 1984.PubMedCrossRefGoogle Scholar
  81. 81.
    Paulson DF, Hodge GB Jr, Hinshaw W, the Uro-Oncology Research Group: J Urol 131: 901–902, 1984.PubMedGoogle Scholar
  82. 82.
    Watson RA, Tang DB: The predictve value of prostatic acid phosphatase as a screening test for prostatic cancer. N Engl J Med 303: 497–499, 1980.PubMedCrossRefGoogle Scholar
  83. 83.
    Whitesel JA, Donohue RE, Mani JH, Mohr S, Scanavino R, Augsburger RR, Biber RJ, Fauver HE, Wettlauf er U, Poster RR: Acid phosphatase: Its influence on the management of carcinoma of the prostate. J Urol 131: 70–72, 1984.PubMedGoogle Scholar
  84. 84.
    Killian CS, Emrich LJ, Vargas FP, Yang N, Wang MC, Priore RL, Murphy GP, Chu TM: Relative reliability of five serially measured markers for prognosis in prostate cancer. J Natl Cancer Inst 76: 179–185, 1986.PubMedGoogle Scholar
  85. 85.
    Oesterling JE, Chan DW, Epstein JJ, Kimball AW, Bruzek DJ, Rock RC, Brendler CB, Walsh PC: Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy. J Urol 139: 766–772, 1988.PubMedGoogle Scholar
  86. 86.
    Kramer SA, Cline WA Jr, Farnham R, et al.: Prognosis of patients with Stage D1 prostatic adenocarcinoma. J Urol 125: 817–819, 1981.PubMedGoogle Scholar
  87. 87.
    Paulson DF, Cline WA Jr, Koefoot RB Jr, Hinshaw W, Stephani S, Uro-Oncology Research Group: J Urol 127: 935–937, 1982.PubMedGoogle Scholar
  88. 88.
    Barzell W, Bean MA, Hilaris BS, Whitmore WF Jr: Prostatic adenocarcinoma: Relationship of grade and local extent to the pattern of metastases. J Urol 118: 278–282, 1977.PubMedGoogle Scholar
  89. 89.
    Golimbu M, Morales P, A1-Askari S, Brown J: Extended pelvic lymphadenectomy for prostatic cancer. J Urol 121: 617–620, 1979.PubMedGoogle Scholar
  90. 90.
    Myers RP, Zincke H, Fleming TR, Farrow GM, Furlow WL, Utz DC: Hormonal treatment at time of radical retropubic prostatectomy for Stage Dl prostate cancer. J Urol 130: 99–101, 1983.PubMedGoogle Scholar
  91. 91.
    Grossman HB, Batata M, Hilaris B, Whitmore WF Jr: 125I implantation for carcinoma of prostate: Further follow-up of first 100 cases. Urology 20: 591–598, 1982.PubMedCrossRefGoogle Scholar
  92. 92.
    Smith JA, Middle ton RG: Implications of volume of nodal metastasis in patients with adenocarcinoma of the prostate. J Urol: 617, 1985.Google Scholar
  93. 93.
    Catalona WJ, Dressner SM: Nerve sparing radical prostatectomy: Extraprostatic tumor extension and preservation of erectile function. J Urol 134: 1149–1151, 1985.PubMedGoogle Scholar
  94. 94.
    Pontes JE, Wajman Z, Huben RP, Wolf RM, Englander LS: Prognostic factors in localized prostatic carcinoma. J Urol 134: 1137–1139, 1985.PubMedGoogle Scholar
  95. 95.
    Fowler JE, Mills SE: Operable prostatic carcinoma: Correlations among clinical stage, pathological stage, Gleason histological score and early disease-free interval. J Urol 133: 49–52, 1985.PubMedGoogle Scholar
  96. 96.
    Parfitt HE Jr, Smith JA Jr, Seaman JP, Middleton RG: Surgical treatment of Stage A2 prostatic carcinoma: Significance of tumor grade and extent. J Urol 129: 763–765, 1983.PubMedGoogle Scholar
  97. 97.
    Lange PH, Narayan P: Understaging and undergrading of prostate cancer. Urol 21: 113–118, 1983.PubMedCrossRefGoogle Scholar
  98. 98.
    Bass RB Jr, Barrett DM: Radical retropubic prostatectomy after transurethral prostatic resection. J Urol 124: 495–497, 1980.PubMedGoogle Scholar
  99. 99.
    Nichols RT, Barry JM, Hodges CV: The morbidity of radical prostatectomy for multifocal Stage 1 prostatic adenocarcinoma. J Urol 117: 83–84, 1977.PubMedGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Boston 1989

Authors and Affiliations

  • Herbert Lepor

There are no affiliations available

Personalised recommendations